Currently covering UK for antimicrobial portfolio (viral, bacterial and fungal infections) supporting a large cross-functional team of office- and field-based colleagues. Focus on articulating the impact of prescribing decisions on Healthcare Systems through Health Economics, using models and data from Clinical and NHS sources, in population-level discussions with Area, Regional and National NHS stakeholders. Demonstration of: Budget Impact, Cost Effectiveness, resource burden; impact on Commissioners, Providers, patients and clinicians; alignment with key priorities. Includes environmental scanning leading to strategy development and creation for approval of Health Economic models, data dashboards and additional material, for use by self and colleagues, during promotional and non-promotional discussions to clarify challenges and help develop solutions. Projects include supporting wider national and global colleagues, for example in areas of business development, adaption of UK solutions for international markets, activity prioritisation and co-authoring of Health Economic work for abstract/poster presentation and publication.

Privileged to have served as a non-professional Member-Nominated Trustee Director of employer's Company Pension Scheme. Board-level responsibilities for UK Pension Scheme. Appointed to Governance & Risk Management subcommittee with oversight of regulatory compliance. Membership of Investment subcommittee with responsibility for £multi-billion portfolio. Included period of transition to new PCST Scheme Governance structure.

Territory management of high value product late in product life cycle and country-leading performance during launch of new product in new medicine class.Working with key internal and external stakeholders to development compelling value propositions based on Local, Regional and National challengesRecognised for "Gold Standard" approach to Business Planning and Account ManagementKeen ability to leverage Health Economic concepts and NHS drivers in development of patient-, provider-and system-level solutions.Proactive identification of high performing behaviour and critical success factors to drive best practice through cross-company project working.CRM system development and implementationReputation work streamTraining and Development of colleagues

Joined new Market Access Development team created to launch the use of a vaccines product outside of national tender for new indication.Identified and developed opportunities in Secondary Care, Primary Care and Public Health where no prior relationship existed.Delivered country-leading guideline development performance.

Promotion of medicines at a range of stages within product life cycle from product launch to loss of exclusivity.Successfully worked with healthcare professionals to develop formularies, protocols and guidelines in a range of disease areas: Cardiovascular, Mental Health, Urology, Respiratory and Pain Management.

Development and implementation of New Product Launch